Abstract
We previously performed a systematic analysis of free ceramide (Cers) species, the constituent ceramide species of sphingomyelins and neutral glycosphingolipids (NGSLs) using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with high-energy collision-induced dissociation. As a result, distinct species differences were found among Cers, sphingomyelins and NGSLs in the kidneys. Using this method, we investigated various sphingolipid species from human colon cancer Caco-2 cells as well as the influence of environmental oxygen on these species in detail. Unexpectedly, even in normoxia, all Cers species were composed of dihydrosphingosine (d18:0) and non-hydroxy fatty acid (NFA), and 34 % of sphingomyelins were composed of dihydrosphingomyelins with NFA. In contrast, major constituent ceramide species of NGSLs were composed of the usual long-chain base of sphingosine (d18:1) and hydroxy fatty acid (HFA). When the cells were cultured under hypoxic condition for 3 days, all the Cers and nearly 80 % of the sphingomyelins were dihydrosphingolipids composed of d18:0-NFAs, but a significant proportion of d18:1-HFAs still remained in the NGSLs. When the cells were transferred from conditions of hypoxia to normoxia again (reoxygenation), Cer species composed of d18:1-NFAs, which were not found in Cers under the original normoxic conditions, appeared. Such Cers were probably synthesized as precursors for the constituent ceramides of sphingomyelins and NGSLs.
Similar content being viewed by others
References
Merrill Jr., A.H.: Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem. Rev. 111, 6387–6422 (2011)
Bielawski, J., Pierce, J.S., Snider, J., Rembiesa, B., Szulc, Z.M., Bielawska, A.: Comprehensive quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods Mol. Biol. 579, 443–467 (2009)
Haynes, C.A., Allegood, J.C., Park, H., Sullards, M.C.: Sphingolipidomics: methods for the comprehensive analysis of sphingolipids. J. Chromatogr., B 877, 2696–2708 (2009)
Grösch, S., Schiffmann, S., Geisslinger, G.: Chain length-specific properties of ceramides. Prog. Lipid Res. 51, 50–62 (2012)
Buschard, K., Blomqvist, M., Månsson, J.E., Fredman, P., Juhl, K., Gromada, J.: C16:0 sulfatide inhibits insulin secretion in rat beta-cells by reducing the sensitivity of KATP channels to ATP inhibition. Diabetes 55, 2826–2834 (2006)
Iwabuchi, K., Prinetti, A., Sonnino, S., Mauri, L., Kobayashi, T., Ishii, K., Kaga, N., Murayama, K., Kurihara, H., Nakayama, H., Yoshizaki, F., Takamori, K., Ogawa, H., Nagaoka, I.: Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophils. Glycoconj J. 25, 357–374 (2008)
Karahatay, S., Thomas, K., Koybasi, S., Senkal, C.E., Elojeimy, S., Liu, X., Bielawski, J., Day, T.A., Gillespie, M.B., Sinha, D., Norris, J.S., Hannun, Y.A., Ogretmen, B.: Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis. Cancer Lett. 256, 101–111 (2007)
Signorelli, P., Munoz-Olaya, J.M., Gagliostro, V., Casas, J., Ghidoni, R., Fabriàs, G.: Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells. Cancer Lett. 282, 238–243 (2009)
Fabrias, G., Muñoz-Olaya, J., Cingolani, F., Signorelli, P., Casas, J., Gagliostro, V., Ghidoni, R.: Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena. Prog. Lipid Res. 51, 82–94 (2012)
Deeley, J.M., Hankin, J.A., Friedrich, M.G., Murphy, R.C., Truscott, R.J., Mitchell, T.W., Blanksby, S.J.: Sphingolipid distribution changes with age in the human lens. J. Lipid Res. 51, 2753–2760 (2010)
Hama, H.: Fatty acid 2-Hydroxylation in mammalian sphingolipid biology. Biochim. Biophys. Acta 1801, 405–414 (2010)
Tanaka, K., Yamada, M., Tamiya-Koizumi, K., Kannagi, R., Aoyama, T., Hara, A., Kyogashima, M.: Systematic analyses of free ceramide species and ceramide species comprising neutral glycosphingolipids by MALDI-TOF MS with high-energy CID. Glycoconj J. 28, 67–87 (2011)
Devlin, C.M., Lahm, T., Hubbard, W.C., Van Demark, M., Wang, K.C., Wu, X., Bielawska, A., Obeid, L.M., Ivan, M., Petrache, I.: Dihydroceramide-based response to hypoxia. J. Biol. Chem. 286, 38069–38078 (2011)
Saito, T., Hakomori, S.I.: Quantitative isolation of total glycosphingolipids from animal cells. J. Lipid Res. 12, 257–259 (1971)
Kyogashima, M., Tadano-Aritomi, K., Aoyama, T., Yusa, A., Goto, Y., Tamiya-Koizumi, K., Ito, H., Murate, T., Kannagi, R., Hara, A.: Chemical and apoptotic properties of hydroxy-ceramides containing long-chain bases with unusual alkyl chain lengths. J. Biochem. 144, 95–106 (2008)
Kyogashima, M., Tamiya-Koizumi, K., Ehara, T., Li, G., Hu, R., Hara, A., Aoyama, T., Kannagi, R.: Rapid demonstration of diversity of sulfatide molecular species from biological materials by MALDI-TOF MS. Glycobiology 16, 719–728 (2006)
Szulc, Z.M., Bai, A., Bielawski, J., Mayroo, N., Miller, D.E., Gracz, H., Hannun, Y.A., Bielawska, A.: Synthesis, NMR characterization and divergent biological actions of 20-hydroxy-ceramide/dihydroceramide stereoisomers in MCF7 cells. Bioorg. Med. Chem. 18, 7565–7579 (2010)
Rylova, S.N., Somova, O.G., Zubova, E.S., Dudnik, L.B., Kogtev, L.S., Kozlov, A.M., Alesenko, A.V., Dyatlovitskaya, E.V.: Content and structure of ceramide and sphingomyelin and sphingomyelinase activity in mouse hepatoma-22. Biochemistry (Mosc). 64, 437–441 (1999)
Dyatlovitskaya, E.V., Kandyba, A.G., Kozlov, A.M., Somova, O.G.: Sphinganine in Sphingomyelins of tumors and mouse regenerating liver. Biochemistry (Mosc). 66, 502–504 (2001)
Semenza, G.L.: Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 35, 71–103 (2000)
Svensson, M., Lindstedt, R., Radin, N.S., Svanborg, C.: Epithelial glucosphingolipid expression as a determinant of bacterial adherence and cytokine production. Infect. Immun. 62, 4404–4410 (1994)
Kyogashima, M., Taketomi, T.: Lipids from human platelets in primary thrombocythemia. Jpn. J. Exp. Med. 56, 113–118 (1986)
Ji, L., Zhang, G., Uematsu, S., Akahori, Y., Hirabayashi, Y.: Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett. 358, 211–214 (1995)
Tani, M., Kuge, O.: Hydroxylation state of fatty acid and long-chain base moieties of sphingolipid determine the sensitivity to growth inhibition due to AUR1 repression in Saccharomyces cerevisiae. Biochem. Biophys. Res. Commun. 417, 673–678 (2012)
Michel, C., van Echten-Deckert, G., Rother, J., Sandhoff, K., Wang, E., Merrill Jr., A.H.: Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide. J. Biol. Chem. 272, 22432–22437 (1997)
Stanley, P.: Golgi glycosylation. Cold Spring Harb Perspect Biol. (2011) 3(4). doi:10.1101/cshperspect.a005199
Miyazaki, M., Ntambi, J.M.: Fatty acid desaturation and chain elongation in mammals. In: Vance, D.E., et al. (eds.) Biochemistry of lipids, lipoproteins and membranes, 5th edn, pp. 191–211. Elsevier, Amsterdam (2008)
Kannagi, R., Stroup, R., Cochran, N.A., Urdal, D.L., Young Jr., W.W., Hakomori, S.: Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells. Cancer Res. 43, 4997–5005 (1983)
Nishimura, K.: Phytosphingosine is a characteristic component of the glycolipids in the vertebrate intestine. Comp Biochem Physiol B. 86, 149–154 (1987)
Omae, F., Miyazaki, M., Enomoto, A., Suzuki, M., Suzuki, Y., Suzuki, A.: DES2 protein is responsible for phytoceramide biosynthesis in the mouse small intestine. Biochem. J. 379, 687–695 (2004)
Strömberg, N., Karlsson, K.A.: Characterization of the binding of Actinomyces naeslundii (ATCC 12104) and Actinomyces viscosus (ATCC 19246) to glycosphingolipids, using a solid-phase overlay approach. J. Biol. Chem. 265, 11251–11258 (1990)
Hakomori, S.: Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv. Exp. Med. Biol. 491, 369–402 (2001)
Hanada, K.: Intracellular trafficking of ceramide by ceramide transfer protein. Proc Jpn Acad Ser B Phys Biol Sci. 86, 426–437 (2010)
D’Angelo, G., Uemura, T., Chuang, C.C., Polishchuk, E., Santoro, M., Ohvo-Rekilä, H., Sato, T., Di Tullio, G., Varriale, A., D’Auria, S., Daniele, T., Capuani, F., Johannes, L., Mattjus, P., Monti, M., Pucci, P., Williams, R.L., Burke, J.E., Platt, F.M., Harada, A., De Matteis, M.A.: Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi. Nature 501, 116–120 (2013)
Domonand, B., Costello, C.E.: A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates. Glycoconj. J. 5, 397–409 (1988)
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplemental Fig. 1
Fragmentation scheme and MS/MS profile of the [M + H]+ ion at m/z 540.2 derived from Cer of d18:0-C16:0 and its spectrum (a). MS/MS profile of the [M + H] + ion at m/z 789.9 derived from sphingomyelin d18:0-C22:0. Ion at m/z 184.5 derived from phosphocholine (b). (PDF 187 kb)
Rights and permissions
About this article
Cite this article
Tanaka, K., Tamiya-Koizumi, K., Yamada, M. et al. Individual profiles of free ceramide species and the constituent ceramide species of sphingomyelin and neutral glycosphingolipid and their alteration according to the sequential changes of environmental oxygen content in human colorectal cancer Caco-2 cells. Glycoconj J 31, 209–219 (2014). https://doi.org/10.1007/s10719-013-9511-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-013-9511-9